Raymond James Financial Services Advisors’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-43,826	Closed	-$1.16M	–	3306
2021 Q2	$1.16M	Buy	+43,826	New	+$1.16M	﹤0.01%	1852